Neuronal protein synuclein γ predicts poor clinical outcome in breast cancer

International Journal of Cancer

Volumn 121, Issue 6, 2007, Pages 1296-1305

  Guo, Jianping ^a   Shou, Chengchao ^a   Meng, Lin ^a   Jiang, Beihai ^a   Dong, Bin ^a   Yao, Lihua ^a   Xie, Yuntao ^a   Zhang, Jianzhi ^a   Chen, Yiding ^b   Budman, Daniel R ^b   Yuenian, Eric Shi ^b  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; Chaperone protein; Prognosis; Synuclein gamma

Indexed keywords

ESTROGEN RECEPTOR; GAMMA SYNUCLEIN; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR; TUMOR MARKER;

ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST HYPERPLASIA; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LYMPH NODE METASTASIS; MULTIVARIATE ANALYSIS; NONHUMAN; ONCOGENE NEU; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMMA-SYNUCLEIN; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MICE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 34548101128     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22763     Document Type: Article

References (30)

1. Clayton DF, George JM. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 1998;121:249-54.
2. George JM. The synucleins. Genome Biol 2001;3:3002.1-3002.6.
3. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-47.
4. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. α-Synuclein in Lewy bodies. Nature 1997;388:839-40.
5. Takeda A, Mallory M, Sundsmo M, Honer W, Hansen L Masliah E. Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders. Am J Pathol 1998;152:367-72.
6. Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1993;90:11282-86.
7. Yoshimoto M, Iwai A, Kang D, Otero DA, Xia Y, Saitoh T. NACP, the precursor protein of the non-amyloid β/A4 protein (A β) component of Alzheimer disease amyloid, binds A β and stimulates A β aggregation. Proc Natl Acad Sci USA 1995;92:9141-45.
8. Duda JE, Lee VM, Trojanowski JQ. Neuropathology of synuclein aggregates. J Neurosci Res 2000;61:121-7.
9. Ji H, Liu YE, Jia T, Wang M, Liu J, Xiao G, Joseph BK, Rosen C, Shi YE. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res 1997;57:759-64.
10. Wu K, Weng Z, Tao Q, Lin G, Wu X, Qian H, Zhang Y, Ding X, Jiang Y, Shi YE. Stage-specific expression of breast cancer-specific gene γ synuclein. Cancer Epidemiol Biomarkers Prev 2003;12:920-5.
11. Bruening W, Giasson BI, Klein-Szanto AJ, Lee VM, Trojanowski JQ, Godwin AK. Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer 2000;88:2154-63.
12. Gupta A, Godwin AK, Vanderveer L, Lu A, Liu J. Hypomethylation of the synuclein γ gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Cancer Res 2003;63:664-73.
13. Lavedan C, Leroy E, Dehejia A, Buchholtz S, Dutra A, Nussbaum RL, Polymeropoulos MH. Identification, localization and characterization of the human γ-synuclein gene. Hum Genet 1998;103:106-12.
14. Liu H, Liu W, Wu Y, Zhou Y, Xue R, Luo C, Wang L, Zhao W, Jiang JD, Liu J. Loss of epigenetic control of synuclein-γ gene as a molecular indicator of metastasis in a wide range of human cancers. Cancer Res 2005;65:7635-43.
15. Jiang Y, Liu YE, Goldberg ID, Shi YE. γ Synuclein, a novel heat-shock protein-associated chaperone, stimulates ligand-dependent estrogen receptor α signaling and mammary tumorigenesis. Cancer Res 2004;64:4539-46.
16. Jia T, Liu YE, Liu J, Shi YE. Stimulation of breast cancer invasion and metastasis by synuclein γ. Cancer Res 1999;59:742-47.
17. Jiang Y, Liu YE, Lu A, Gupta A, Goldberg ID, Liu J, Shi YE. Stimulation of estrogen receptor signaling by γ synuclein. Cancer Res 2003;63:3899-3903.
18. Gupta A, Inaba S, Wong OK, Fang G, Liu J. Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1. Oncogene 2003;22:7593-99.
19. Inaba S, Li C, Shi YE, Song DQ, Jiang JD, Liu J. Synuclein γ inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells. Breast Cancer Res Treat 2005;94:25-35.
20. Wu K, Quan Z, Weng Z, Li F, Zhang Y, Yao X, Chen Y, Budman D, Goldberg ID, Shi YE. Expression of neuronal protein synuclein γ gene as a novel marker for breast cancer prognosis. Breast Cancer Res Treat 2007;101:259-67.
21. Pan ZZ, Bruening W, Giasson BI, Lee VM, Godwin AK. Γ-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways. J Biol Chem 2002:277:35050-60.
22. Liu J, Spence MJ, Zhang YL, Jiang Y, Liu YE, Shi YE. Transcriptional suppression of synuclein γ (SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin M. Breast Cancer Res Treat 2000;62:99-107.
23. Hetian L, Ping A, Shumei S, Xiaoying L, Luowen H, Jian W, Lin M, Meisheng L, Junshan Y, Chengchao S. A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor. J Biol Chem 2002;277:43137-42.
24. Molino A, Micciolo R, Turazza M, Bonetti F, Piubello Q, Corgnati A, Sperotto L, Recaldin E, Spagnolli P, Manfrin E, Bonetti A, Nortilli R et al. Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods. Breast Cancer Res Treat 1997;45:241-9.
25. Liu YE, Pu W, Jiang Y, Shi D, Dackour R, Shi YE. Chaperoning of estrogen receptor and induction of mammary gland proliferation by neuronal protein synuclein γ. Oncogene 2007;26:2115-25.
26. Li Z, Sclabas GM, Peng B, Hess KR, Abbruzzese JL, Evans DB, Chiao PJ. Overexpression of synuclein-γ in pancreatic adenocarcinoma. Cancer 2004;101:58-65.
27. Iwaki H, Kageyama S, Isono T, Wakabayashi Y, Okada Y, Yoshimura K, Terai A, Arai Y, Iwamura H, Kawakita M, Yoshiki T. Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, γ-synuclein, and catechol-o-methyltransferase) identified by proteomic analysis. Cancer Sci 2004;95:955-61.
28. Fung KM, Broke LB, Giasson B, Lee VMY, Trojanowski JQ. 2003. Expression of α-, β-, γ-synuclein in glial tumors and medulloblastomas. Acta Neuropathol 2003;106:167-75.
29. Lu A, Gupta A, Li C, Ahlborn TE, Ma Y, Shi YE, Liu J. Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences. Oncogene 2001;20:5173-85.
30. Wang PL, Huang XF, Xie YQ. A preliminary experimental study on the inhibition of metastasis in human breast cancer by anti-angiogenic drug: thalidomide. Zhong Hua Yi Xue Za Zhi 2005;2:254-57.